FDA Adverse Event Injury Summary report: N

AVAULTA PLUS POSTERIOR BIOSYNTHETIC SUPPORT SYSTEM

MDR report key: 3060260 · Received April 11, 2013

Report

Report Number
1018233-2013-01261
Event Type
Injury
Date Received
April 11, 2013
Report Date
November 4, 2015
Manufacturer
C.R. BARD, INC. (COVINGTON)
Product Code
FTL
PMA / PMN Number
K082571
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
ATTORNEY
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESS POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE REACTIONS: "POTENTIAL ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING HEMATOMA, SEROMA, MUCOSAL OR VISCERAL EROSION, INFECTION, INFLAMMATION, SENSITIZATION, DYSPAREUNIA, SCARIFICATION AND CONTRACTION, FISTULA FORMATION, EXTRUSION AND RECURRENCE OF VAGINAL WALL PROLAPSE. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, RECTUM, OR ANY VISCERA MAY OCCUR DURING NEEDLE PASSAGE." (B)(4).

Description of Event or Problem · 1

THE PT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADDITIONAL INFO HAS BEEN REQUESTED, BUT NOT YET RECEIVED. ASSOCIATED MDR: 1018233-2013-01260.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156390 AVAULTA PLUS POSTERIOR BIOSYNTHETIC SUPPORT SYSTEM Mesh, surgical, polymeric FTL C.R. BARD, INC. (COVINGTON) NA CVRJ0026

Patients

Seq Age Sex Outcome Treatment
1 49 YR Female Required Intervention AVAULTA PLUS ANTERIOR BIOSYNTHETIC SUPPORT SYSTEM| GYECARE TVT OBTURATOR| GYECARE TVT OBTURATOR| AVAULTA PLUS ANTERIOR BIOSYNTHETIC SUPPORT SYSTEM